pattern
pattern

About Industry Data Insights

Industry Data Insights provides industry-focused research and analytical intelligence for organizations seeking a clearer view of market performance, competitive conditions, and long-term business opportunities. Through syndicated reports, customized studies, and strategic research support, Industry Data Insights helps businesses access the information needed to evaluate markets and plan for sustainable growth. Our research covers the full market landscape, including industry structure, historical performance, current demand, value-chain developments, regional trends, customer requirements, technological change, and future growth potential. We examine the factors that influence market outcomes, including economic conditions, supply-chain dynamics, policy and regulatory developments, innovation, investment activity, and changing end-user preferences.

At Industry Data Insights, we use a research framework that brings together credible secondary sources, public and company-level information, industry publications, trade statistics, expert perspectives, and data-led market modeling. Our analysts validate key assumptions and assess multiple market variables to develop balanced, actionable conclusions for business leaders, investors, consultants, and product teams. Industry Data Insights supports a broad range of verticals, including industrial manufacturing, engineering, construction, chemicals, energy and power, healthcare, information technology, telecom, automotive, packaging, agriculture, consumer products, retail, and transportation. Each study is structured to help users understand both the immediate market environment and the longer-term forces that may influence demand and competition. From identifying high-potential segments to assessing a competitor’s position or evaluating a new geography, Industry Data Insights delivers research that is designed to be useful, relevant, and aligned with real business questions. Our goal is to turn industry data into strategic direction.

  • Home
  • About Us
  • Industries
    • Healthcare
    • Technology
    • Advanced Materials
    • Semiconductors & Electronics
    • Specialty & Chemicals
    • Bulk Chemicals
    • Food & Beverages
    • Consumer Goods
  • Services
  • Contact
Publisher Logo
  • Home
  • About Us
  • Industries
    • Healthcare

    • Technology

    • Advanced Materials

    • Semiconductors & Electronics

    • Specialty & Chemicals

    • Bulk Chemicals

    • Food & Beverages

    • Consumer Goods

  • Services
  • Contact
+1 2315155523
[email protected]

+1 2315155523

[email protected]

Publisher Logo
Developing personalize our customer journeys to increase satisfaction & loyalty of our expansion.
award logo 1
award logo 1

Resources

Services

Contact Information

Craig Francis

Business Development Head

+1 2315155523

[email protected]

Leadership
Enterprise
Growth
Leadership
Enterprise
Growth

© 2026 PRDUA Research & Media Private Limited, All rights reserved



About
Contacts
Testimonials
Services
Customer Experience
Training Programs
Business Strategy
Training Program
ESG Consulting
Development Hub
Healthcare
Technology
Bulk Chemicals
Consumer Goods
Food & Beverages
Advanced Materials
Specialty & Chemicals
Semiconductors & Electronics
Privacy Policy
Terms and Conditions
FAQ
banner overlay
Report banner
Artificial Intelligence Oncology Market Report
Updated On

Nov 18 2026

Total Pages

274

Shweta Thorat

Shweta Thorat

Research Associate

Artificial Intelligence Oncology Market Report 2026

Artificial Intelligence Oncology Market Report by Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Other Solid Malignancies), by Application (Diagnostics & Screening, Pathology, Radiation Therapy Planning, R&D and Drug Discovery, Clinical Decision Support, Patient Monitoring), by Product Type (Software, Services, Enabling Hardware), by End User (Hospitals, Pharmaceutical Companies, Research Institutes, Diagnostic Labs), by North America (USA, Canada, Mexico), by Europe (Germany, UK, France, Italy, Spain), by Asia Pacific (China, Japan, India, South Korea, Australia), by Latin America (Brazil, Argentina, Mexico), by Middle East & Africa (Saudi Arabia, UAE, South Africa) Forecast 2026-2034
Publisher Logo

Artificial Intelligence Oncology Market Report 2026


Discover the Latest Market Insight Reports

Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.

shop image 1
Home
Industries
Advanced Materials

Get the Full Report

Unlock complete access to detailed insights, trend analyses, data points, estimates, and forecasts. Purchase the full report to make informed decisions.

Author

Shweta Thorat

Shweta Thorat

Research Associate

I am a Research Associate specializing in the Packaging & Transport sector, dedicated to delivering actionable insights through structured primary and secondary market analysis. My core expertise lies in comprehensive report development, competitive benchmarking, and market sizing studies, with a focus on analyzing industry trends and evaluating key players. Driven by data-driven methodologies, I translate complex data into clear, strategic recommendations that identify growth opportunities and support business decision-making.

Search Reports

Looking for a Custom Report?

We offer personalized report customization at no extra cost, including the option to purchase individual sections or country-specific reports. Plus, we provide special discounts for startups and universities. Get in touch with us today!

Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo
Sponsor Logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Verified Client
5.0

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

Jared Wan

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

Verified Industry Buyer100% Authentic
Verified Client
5.0

The rebate management software market report exceeded our expectations in both quality and actionable intelligence. It provides a clear, data-driven foundation for our future growth strategies across the U.S. and Asia-Pacific. We are very satisfied with the results and the professional support provided throughout the process.

Lars Pedersen

Lars Pedersen

Market Strategy Executive

Verified Industry Buyer100% Authentic
Verified Client
5.0

The market report we received is excellent and aligns closely with the data we can verify based on our own industry knowledge. We are very happy with the quality of the content and the insights provided by the team. As a result of this positive experience, we are moving forward with the purchase of four additional reports.

Lina Lim

Lina Lim

Market Strategy Executive

Verified Industry Buyer100% Authentic
Verified Client
5.0

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

Verified Industry Buyer100% Authentic
Verified Client
5.0

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

Erik Perison

US TPS Business Development Manager at Thermon

Verified Industry Buyer100% Authentic

Related Reports

See the similar reports

report thumbnailVeterinary Stents Market Report

Veterinary Stents Market Report: Size, CAGR & 2035 Outlook

report thumbnailArea Rugs Market Report

Area Rugs Market Report: Size, Share & Growth 2026

report thumbnailUs Frozen Snacks Market Report

US Frozen Snacks Market Report 2026: Size, Share & Forecast

report thumbnailNoble Gases Market

Noble Gases Market Size, Share & Forecast to 2032

report thumbnailDeep Learning Market

Deep Learning Market Size, Growth & Forecast to 2033

report thumbnailMiddle East Coiled Tubing Market Report

Middle East Coiled Tubing Market Report 2025

report thumbnailArtificial Intelligence Oncology Market Report

Artificial Intelligence Oncology Market Report 2026

report thumbnailHealthcare E Learning Services Market Report

Healthcare E Learning Services Market Report 2025

report thumbnailHemorrhagic Ischemic Stroke Treatment Devices Market Report

Hemorrhagic Ischemic Stroke Treatment Devices Market Report 2026

report thumbnailNetwork Repeaters Market Report

Network Repeaters Market Report: 2026 Size, Share & Forecast

report thumbnailMultiexperience Development Platforms Market

Multiexperience Development Platforms Market 2026

report thumbnailOnline Travel Agencies Market Report

Online Travel Agencies Market Report: 2026 Global Outlook

report thumbnailBone Morphogenetic Proteins Market

Bone Morphogenetic Proteins Market Outlook 2025

report thumbnailAutomotive Sensors Market

Automotive Sensors Market: Global Size, Share & 2031 Forecast

report thumbnailMechanical Anchors Market Report

Mechanical Anchors Market Report: Size, Share & Forecast 2033

report thumbnailEndodontic Devices Market

Endodontic Devices Market: 2025 Size, Share & 2030 Forecast

report thumbnailDrug Discovery Informatics Market

Drug Discovery Informatics Market: Size, CAGR & Forecast 2026

report thumbnailTaiwan Liquid Dietary Supplements Market Report

Taiwan Liquid Dietary Supplements Market Report 2025

report thumbnailOutdoor Fabric Market

Outdoor Fabric Market Size, Share & Forecast to 2030

report thumbnailMiddle East Food Service Equipment Market Report

Middle East Food Service Equipment Market Report 2026

Artificial Intelligence Oncology Market Report CAGR, market size, market share

Key Takeaways

  • USD 3.1 Billion in 2025 across the global Artificial Intelligence Oncology Market Report scope; forecast USD 32 Billion by 2035 at 27.2% CAGR (2026–2035).
  • Base-year 2025 valuation sits near USD 3.06 Billion on a narrower clinical-AI definition; the 2026 step-up to USD 3.7 Billion reflects enterprise procurement, not new algorithms.
  • Diagnostics and image interpretation remain the largest application cluster, with radiology representing roughly three quarters of ML-enabled device authorizations.
  • North America holds approximately 44% of global revenue; Asia-Pacific is the fastest-growing region on screening capacity and government digitization funding.
  • Top five vendors (Tempus, Flatiron Health, NVIDIA, Guardant Health, Paige AI) held about 45% of 2025 revenue, with Tempus above 9%.
  • Consolidation toward longitudinal oncology platforms is the dominant strategic signal; point solutions face channel-partnership or acquisition routes to scale.
  • Why this matters for decision-makers: Buyers should underwrite interoperability, validation and clinical governance now, because those three criteria — not raw algorithm accuracy — will determine which contracts renew in 2028.
Artificial Intelligence Oncology Market Report Market Size (In Billion)
15.0B
10.0B
5.0B
0
3.100 B
2025
3.700 B
2026
4.700 B
2027
6.000 B
2028
7.600 B
2029
9.700 B
2030
12.30 B
2031
Artificial Intelligence Oncology Market Report Market Size (In Billion)
YearMarket Size
20253.100 B
20263.700 B
20274.700 B
20286.000 B
20297.600 B
20309.700 B
203112.30 B
Publisher Logo

What is the Artificial Intelligence Oncology Market Report?

The Artificial Intelligence Oncology Market Report is a decision-support study of AI software, enabling hardware and services used across cancer detection, diagnosis, pathology, treatment planning, drug discovery and care delivery. It sizes the market, segments it by cancer type, application and end user, and benchmarks vendors, pricing and procurement risk through 2035.

Scope: what this report covers and excludes

This analysis covers global AI oncology spend from 2022 through 2035, with 2025 as the base year and 2026–2035 as the forecast horizon. Coverage spans software, enabling hardware and services across hospitals, pharmaceutical sponsors, research institutes and diagnostic laboratories. This analysis does not cover conventional oncology therapeutics, standard-of-care imaging hardware refresh cycles, or general-purpose enterprise IT unrelated to oncology workflows.

How big is the market for Artificial Intelligence Oncology Market Report?

The defensible consensus is USD 3.1 Billion in 2025 growing to USD 32 Billion by 2035 at 27.2% CAGR — the mid-point between narrow clinical-AI definitions and broader hardware-inclusive scopes. Competing published estimates diverge widely because each defines the addressable unit differently.

Estimate Base year Horizon CAGR Definition / scope Attribution
USD 3.1 Billion 2025 2035 (USD 32 Billion) 27.2% AI software, enabling hardware, services across oncology workflows One published industry estimate
USD 2.4 Billion 2025 2035 (USD 9.1 Billion) 14.1% Platform-centric software spend, excluding most hardware A competing analysis
USD 5.1 Billion 2024 2034 (USD 53.1 Billion) 26.4% Software, services and oncology AI hardware bundled A competing analysis

Our analysis suggests the 27.2% trajectory is most defensible for procurement planning, because it captures enterprise platform deals without inflating the base with general imaging hardware. The 14.1% view likely undercounts embedded AI revenue bundled inside imaging and treatment-planning systems; the 26.4% view likely overstates near-term hardware capture.

How is the market segmented?

Segmentation is by cancer type, application, product type and end user, and the mix determines which vendors can win enterprise contracts versus departmental pilots. Solid malignancies and breast cancer dominate current spend, while pathology and treatment planning are the fastest-moving application clusters.

Parent segment Children
By Cancer Type Breast, Lung, Prostate, Colorectal, Brain Tumor, Other Solid Malignancies
By Application Diagnostics & Screening, Pathology, Radiation Therapy Planning, R&D and Drug Discovery, Clinical Decision Support, Patient Monitoring
By Product Type Software, Services, Enabling Hardware
By End User Hospitals, Pharmaceutical Companies, Research Institutes, Diagnostic Labs

Which region leads in Artificial Intelligence Oncology Market Report?

North America leads with roughly 44% of 2025 global revenue, supported by FDA authorization volume, precision-oncology reimbursement pathways and mature PACS and EHR integration. Asia-Pacific is the fastest-growing region, driven by screening capacity gaps and public digitization funding.

Artificial Intelligence Oncology Market Report Regional Market Share
Loading chart...
Artificial Intelligence Oncology Market Report Regional Market Share
RegionMarket Share (%)
North America0.44%
Europe0.26%
Asia-Pacific0.22%
Latin America0.04%
Middle East & Africa0.04%
Publisher Logo
  • Global
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Italy, Spain)
  • Asia-Pacific (China, Japan, India, South Korea, Australia)
  • Latin America (Brazil, Argentina, Mexico)
  • Middle East & Africa (Saudi Arabia, UAE, South Africa)
Region 2025 Share
North America 44%
Europe 26%
Asia-Pacific 22%
Latin America 4%
Middle East & Africa 4%

Europe's share is inflated by device-integrated AI in treatment planning, while Asia-Pacific revenue is more concentrated in screening and triage deployments. This divergence implies vendors need different commercial playbooks by region, not a single global pricing model.

What is driving growth — and what is holding it back?

Demand for early cancer detection is the strongest growth driver, converting AI from a reading aid into throughput infrastructure; implementation cost and regulatory evidence fragmentation are the binding restraints. The net balance favors growth but with highly uneven provider-level adoption.

Factor Direction Evidence strength Mechanism
Early detection demand Driver (+7.4% CAGR impact) High Screening programs face limited specialist reader supply
Cancer prevalence and workflow burden Driver (+6.1%) High Volume of imaging, pathology and molecular review
Precision oncology data synthesis Driver (+5.3%) Medium Multi-data-type interpretation for therapy selection
Digital deployment infrastructure Driver (+4.6%) Medium PACS, EHR and cloud connectivity enabling enterprise AI
Broad implementation cost Restraint (−3.8%) High Digitization, integration, training and monitoring spend
Regulatory evidence fragmentation Restraint (−3.1%) Medium Multijurisdictional validation and governance burden

A randomized mammography study found AI-supported reading cut screen-reading workload by 44% while maintaining detection performance, which is the clearest published evidence that economics — not accuracy — now drive adoption. The restraint side is equally concrete: digital pathology capital costs can equal or exceed the software contract itself.

Who are the leading vendors?

Tempus leads with over 9% of 2025 revenue, and the top five players collectively hold about 45%, indicating a market that is concentrated at the top but still fragmented across hundreds of point solutions. Differentiation increasingly rests on data assets and integration depth rather than model performance.

Vendor Position Strategic moat
Tempus Leader, >9% share Multi-modal clinical and molecular data network
Flatiron Health Top five Real-world data from ~280 clinics, 5M+ records
NVIDIA Top five Compute and platform infrastructure across vendors
Guardant Health Top five Precision-oncology testing volume and assay data
Paige AI Top five Digital pathology and regulatory-cleared workflows
GE HealthCare Challenger 85 AI-enabled FDA authorizations, installed imaging base
Siemens Healthineers Challenger Treatment-planning installed base via Varian

Our analysis suggests the durable moats are data rights and installed-base distribution, not algorithm libraries. Vendors without either will increasingly compete on price in narrow indications, compressing margins.

What do buyers and operators need to know?

Buyers should treat AI oncology procurement as a multi-year integration decision, not a software purchase. Mission-critical criteria are interoperability with PACS, pathology and EHR systems; validated performance on the buyer's own population; and a clear post-deployment monitoring plan. Switching costs rise sharply once a vendor is embedded in longitudinal decisions, so reference-site diligence before contracting is essential. Regulatory compliance varies by jurisdiction, and multijurisdictional validation remains a documented restraint. Budget for digitization, interface work, cybersecurity review and staff training, which can rival the license fee. Contracts should specify performance-monitoring obligations and data portability to avoid lock-in.

Strategic Recommendations & Analyst Perspective

The balance of evidence favors the 27.2% CAGR trajectory, with enterprise platform deals — not point algorithms — as the revenue engine through 2030. The strongest counter-argument is that reimbursement uncertainty in screening could cap hospital budgets; however, workload-reduction evidence and precision-oncology data requirements make AI spend defensive rather than discretionary. The risk is not demand, it is execution capacity at the provider level.

Our analysis suggests vendors that pair regulated applications with implementation services and reusable data assets will capture a disproportionate share of enterprise contracts, while single-task suppliers will be acquired or relegated to channel partnerships. Investors should underwrite interoperability and governance capability, because those determine renewal economics after the first contract cycle.

  • Prioritize interoperability and clinical governance proof-points in diligence, not model accuracy benchmarks.
  • Target Asia-Pacific screening and triage deployments for volume growth; target North America for margin.
  • Structure contracts with data portability and monitoring clauses to limit switching-cost exposure.

What would change this conclusion: sustained reimbursement rejection for AI-assisted screening in two or more major markets, or evidence that generic foundation models erode vendor pricing power faster than platform consolidation can offset.

Artificial Intelligence Oncology Market Report Regional Market Share

Higher Coverage
Lower Coverage
No Coverage

Artificial Intelligence Oncology Market Report REPORT HIGHLIGHTS

Research Methodology & Data Sources

Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.

Primary Research & Industry Fieldwork

This study applies a 70/30 primary-to-secondary research split. In-depth interviews were conducted with stakeholders across the AI oncology value chain, including imaging and pathology software developers, enabling-hardware suppliers, clinical AI integrators, hospital IT and informatics procurement teams, and pharmaceutical R&D data leads. Interviewees were drawn from decision-maker designations including Chief Medical Information Officers, Heads of Oncology Informatics, VP-level Procurement and Sourcing Leads, and Regulatory Affairs Directors, ensuring coverage of both technical validation and commercial contracting dynamics.

Key Stakeholders Interviewed

Publisher Logo
Key Stakeholders Interviewed
Stakeholder RoleInterview Share (%)
Clinical Informatics & Medical Leadership40%
Procurement & Sourcing Leads30%
Regulatory Affairs Directors20%
R&D and Data Science Heads10%

Industry Ecosystem Breakdown

Publisher Logo
Industry Ecosystem Breakdown
Company TypeRepresentation (%)
AI Software & Platform Developers40%
Imaging & Enabling Hardware Suppliers25%
Clinical Integrators & Service Providers20%
Pharma & Research Data Users15%

Secondary Benchmarking & Public Trade Validation

Secondary validation drew on official regulatory authorization databases, corporate annual filings and investor presentations (10-K and SEC filings), patent databases, and recognized non-profit technical standards and clinical association publications. Cross-border trade statistics from UN Comtrade, Eurostat and national statistics offices were used to validate regional revenue allocation where device-integrated AI revenue crosses borders.

Demand Modeling & Market Sizing Triangulation

Market sizing combined top-down allocation from oncology diagnostics and software spend with bottom-up modeling of vendor revenue, installed-base capacity and end-user consumption across hospitals, pharmaceutical sponsors and research institutes. Scenario weights were applied to conservative, base and optimistic cases to bound forecast uncertainty.

Data Triangulation & Validation Matrix

Dimension Analytical Scope Methodology Applied Validation Level
Base-Year Market Size Value in USD for base year Bottom-up revenue triangulation High
Forecast Horizon Multi-year compound projection Historical CAGR, regression and demand elasticity High
Regional Distribution Regional share breakdown Cross-border trade flow and regional consumption High
Competitive Landscape Leading market players Annual reports, capacity mapping, commercial filings High

Sources Referenced

  • U.S. Food and Drug Administration (FDA) medical device and oncology authorization databases
  • WHO / International Agency for Research on Cancer (IARC) global cancer burden statistics
  • National Cancer Institute (NCI) AI benchmarking and research initiatives
  • UN Comtrade and Eurostat trade and health-spend statistics
AspectsDetails
Study Period2020-2034
Base Year2025
Estimated Year2026
Forecast Period2026-2034
Historical Period2020-2025
Growth RateCAGR of 27.2% from 2020-2034
Segmentation
    • By Cancer Type
      • Breast Cancer
      • Lung Cancer
      • Prostate Cancer
      • Colorectal Cancer
      • Brain Tumor
      • Other Solid Malignancies
    • By Application
      • Diagnostics & Screening
      • Pathology
      • Radiation Therapy Planning
      • R&D and Drug Discovery
      • Clinical Decision Support
      • Patient Monitoring
    • By Product Type
      • Software
      • Services
      • Enabling Hardware
    • By End User
      • Hospitals
      • Pharmaceutical Companies
      • Research Institutes
      • Diagnostic Labs
  • By Geography
    • North America
      • USA
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Argentina
      • Mexico
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa

Table of Contents

  1. 1. Artificial Intelligence Oncology Market Report Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Objective
    • 1.4. Definitions and Assumptions
  2. 2. Artificial Intelligence Oncology Market Report Executive Summary
    • 2.1. Market Snapshot
  3. 3. Artificial Intelligence Oncology Market Report Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.3. Market Restrains
        • 3.4. Market Trends
        • 4. Artificial Intelligence Oncology Market Report Factor Analysis
          • 4.1. Porters Five Forces
            • 4.1.1. Bargaining Power of Suppliers
            • 4.1.2. Bargaining Power of Buyers
            • 4.1.3. Threat of New Entrants
            • 4.1.4. Threat of Substitutes
            • 4.1.5. Competitive Rivalry
          • 4.2. PESTEL analysis
          • 4.3. BCG Analysis
            • 4.3.1. Stars (High Growth, High Market Share)
            • 4.3.2. Cash Cows (Low Growth, High Market Share)
            • 4.3.3. Question Mark (High Growth, Low Market Share)
            • 4.3.4. Dogs (Low Growth, Low Market Share)
          • 4.4. Ansoff Matrix Analysis
          • 4.5. Supply Chain Analysis
          • 4.6. Regulatory Landscape
          • 4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
          • 4.8. IDI Analyst Note
        • 5. Artificial Intelligence Oncology Market Report Analysis, Insights and Forecast, 2020-2034
          • 5.1. Analysis, Insights and Forecast - by Cancer Type
            • 5.1.1. Breast Cancer
            • 5.1.2. Lung Cancer
            • 5.1.3. Prostate Cancer
            • 5.1.4. Colorectal Cancer
            • 5.1.5. Brain Tumor
            • 5.1.6. Other Solid Malignancies
          • 5.2. Analysis, Insights and Forecast - by Application
            • 5.2.1. Diagnostics & Screening
            • 5.2.2. Pathology
            • 5.2.3. Radiation Therapy Planning
            • 5.2.4. R&D and Drug Discovery
            • 5.2.5. Clinical Decision Support
            • 5.2.6. Patient Monitoring
          • 5.3. Analysis, Insights and Forecast - by Product Type
            • 5.3.1. Software
            • 5.3.2. Services
            • 5.3.3. Enabling Hardware
          • 5.4. Analysis, Insights and Forecast - by End User
            • 5.4.1. Hospitals
            • 5.4.2. Pharmaceutical Companies
            • 5.4.3. Research Institutes
            • 5.4.4. Diagnostic Labs
          • 5.5. Analysis, Insights and Forecast - by Region
            • 5.5.1. North America
            • 5.5.2. Europe
            • 5.5.3. Asia Pacific
            • 5.5.4. Latin America
            • 5.5.5. Middle East & Africa
        • 6. Artificial Intelligence Oncology Market Report North America Analysis, Insights and Forecast, 2020-2034
          • 6.1. Analysis, Insights and Forecast - by Cancer Type
            • 6.1.1. Breast Cancer
            • 6.1.2. Lung Cancer
            • 6.1.3. Prostate Cancer
            • 6.1.4. Colorectal Cancer
            • 6.1.5. Brain Tumor
            • 6.1.6. Other Solid Malignancies
          • 6.2. Analysis, Insights and Forecast - by Application
            • 6.2.1. Diagnostics & Screening
            • 6.2.2. Pathology
            • 6.2.3. Radiation Therapy Planning
            • 6.2.4. R&D and Drug Discovery
            • 6.2.5. Clinical Decision Support
            • 6.2.6. Patient Monitoring
          • 6.3. Analysis, Insights and Forecast - by Product Type
            • 6.3.1. Software
            • 6.3.2. Services
            • 6.3.3. Enabling Hardware
          • 6.4. Analysis, Insights and Forecast - by End User
            • 6.4.1. Hospitals
            • 6.4.2. Pharmaceutical Companies
            • 6.4.3. Research Institutes
            • 6.4.4. Diagnostic Labs
        • 7. Artificial Intelligence Oncology Market Report Europe Analysis, Insights and Forecast, 2020-2034
          • 7.1. Analysis, Insights and Forecast - by Cancer Type
            • 7.1.1. Breast Cancer
            • 7.1.2. Lung Cancer
            • 7.1.3. Prostate Cancer
            • 7.1.4. Colorectal Cancer
            • 7.1.5. Brain Tumor
            • 7.1.6. Other Solid Malignancies
          • 7.2. Analysis, Insights and Forecast - by Application
            • 7.2.1. Diagnostics & Screening
            • 7.2.2. Pathology
            • 7.2.3. Radiation Therapy Planning
            • 7.2.4. R&D and Drug Discovery
            • 7.2.5. Clinical Decision Support
            • 7.2.6. Patient Monitoring
          • 7.3. Analysis, Insights and Forecast - by Product Type
            • 7.3.1. Software
            • 7.3.2. Services
            • 7.3.3. Enabling Hardware
          • 7.4. Analysis, Insights and Forecast - by End User
            • 7.4.1. Hospitals
            • 7.4.2. Pharmaceutical Companies
            • 7.4.3. Research Institutes
            • 7.4.4. Diagnostic Labs
        • 8. Artificial Intelligence Oncology Market Report Asia Pacific Analysis, Insights and Forecast, 2020-2034
          • 8.1. Analysis, Insights and Forecast - by Cancer Type
            • 8.1.1. Breast Cancer
            • 8.1.2. Lung Cancer
            • 8.1.3. Prostate Cancer
            • 8.1.4. Colorectal Cancer
            • 8.1.5. Brain Tumor
            • 8.1.6. Other Solid Malignancies
          • 8.2. Analysis, Insights and Forecast - by Application
            • 8.2.1. Diagnostics & Screening
            • 8.2.2. Pathology
            • 8.2.3. Radiation Therapy Planning
            • 8.2.4. R&D and Drug Discovery
            • 8.2.5. Clinical Decision Support
            • 8.2.6. Patient Monitoring
          • 8.3. Analysis, Insights and Forecast - by Product Type
            • 8.3.1. Software
            • 8.3.2. Services
            • 8.3.3. Enabling Hardware
          • 8.4. Analysis, Insights and Forecast - by End User
            • 8.4.1. Hospitals
            • 8.4.2. Pharmaceutical Companies
            • 8.4.3. Research Institutes
            • 8.4.4. Diagnostic Labs
        • 9. Artificial Intelligence Oncology Market Report Latin America Analysis, Insights and Forecast, 2020-2034
          • 9.1. Analysis, Insights and Forecast - by Cancer Type
            • 9.1.1. Breast Cancer
            • 9.1.2. Lung Cancer
            • 9.1.3. Prostate Cancer
            • 9.1.4. Colorectal Cancer
            • 9.1.5. Brain Tumor
            • 9.1.6. Other Solid Malignancies
          • 9.2. Analysis, Insights and Forecast - by Application
            • 9.2.1. Diagnostics & Screening
            • 9.2.2. Pathology
            • 9.2.3. Radiation Therapy Planning
            • 9.2.4. R&D and Drug Discovery
            • 9.2.5. Clinical Decision Support
            • 9.2.6. Patient Monitoring
          • 9.3. Analysis, Insights and Forecast - by Product Type
            • 9.3.1. Software
            • 9.3.2. Services
            • 9.3.3. Enabling Hardware
          • 9.4. Analysis, Insights and Forecast - by End User
            • 9.4.1. Hospitals
            • 9.4.2. Pharmaceutical Companies
            • 9.4.3. Research Institutes
            • 9.4.4. Diagnostic Labs
        • 10. Artificial Intelligence Oncology Market Report Middle East & Africa Analysis, Insights and Forecast, 2020-2034
          • 10.1. Analysis, Insights and Forecast - by Cancer Type
            • 10.1.1. Breast Cancer
            • 10.1.2. Lung Cancer
            • 10.1.3. Prostate Cancer
            • 10.1.4. Colorectal Cancer
            • 10.1.5. Brain Tumor
            • 10.1.6. Other Solid Malignancies
          • 10.2. Analysis, Insights and Forecast - by Application
            • 10.2.1. Diagnostics & Screening
            • 10.2.2. Pathology
            • 10.2.3. Radiation Therapy Planning
            • 10.2.4. R&D and Drug Discovery
            • 10.2.5. Clinical Decision Support
            • 10.2.6. Patient Monitoring
          • 10.3. Analysis, Insights and Forecast - by Product Type
            • 10.3.1. Software
            • 10.3.2. Services
            • 10.3.3. Enabling Hardware
          • 10.4. Analysis, Insights and Forecast - by End User
            • 10.4.1. Hospitals
            • 10.4.2. Pharmaceutical Companies
            • 10.4.3. Research Institutes
            • 10.4.4. Diagnostic Labs
        • 11. Artificial Intelligence Oncology Market Report Competitive Analysis
          • 11.1. Company Profiles
            • 11.2. Market Entropy
              • 11.2.1. Company's Key Areas Served
              • 11.2.2. Recent Developments
            • 11.3. Company Market Share Analysis, 2026
              • 11.3.1. Top 5 Companies Market Share Analysis
              • 11.3.2. Top 3 Companies Market Share Analysis
            • 11.4. List of Potential Customers
          • 12. Artificial Intelligence Oncology Market Report Research Methodology

            List of Figures

            1. Figure 1: Artificial Intelligence Oncology Market Report Revenue Breakdown (Billion, %) by Region 2026 & 2034
            2. Figure 2: North America Artificial Intelligence Oncology Market Report Revenue (Billion), by Cancer Type 2026 & 2034
            3. Figure 3: North America Artificial Intelligence Oncology Market Report Revenue Share (%), by Cancer Type 2026 & 2034
            4. Figure 4: North America Artificial Intelligence Oncology Market Report Revenue (Billion), by Application 2026 & 2034
            5. Figure 5: North America Artificial Intelligence Oncology Market Report Revenue Share (%), by Application 2026 & 2034
            6. Figure 6: North America Artificial Intelligence Oncology Market Report Revenue (Billion), by Product Type 2026 & 2034
            7. Figure 7: North America Artificial Intelligence Oncology Market Report Revenue Share (%), by Product Type 2026 & 2034
            8. Figure 8: North America Artificial Intelligence Oncology Market Report Revenue (Billion), by End User 2026 & 2034
            9. Figure 9: North America Artificial Intelligence Oncology Market Report Revenue Share (%), by End User 2026 & 2034
            10. Figure 10: North America Artificial Intelligence Oncology Market Report Revenue (Billion), by Country 2026 & 2034
            11. Figure 11: North America Artificial Intelligence Oncology Market Report Revenue Share (%), by Country 2026 & 2034
            12. Figure 12: Europe Artificial Intelligence Oncology Market Report Revenue (Billion), by Cancer Type 2026 & 2034
            13. Figure 13: Europe Artificial Intelligence Oncology Market Report Revenue Share (%), by Cancer Type 2026 & 2034
            14. Figure 14: Europe Artificial Intelligence Oncology Market Report Revenue (Billion), by Application 2026 & 2034
            15. Europe Artificial Intelligence Oncology Market Report Revenue Share (%), by Application 2026 & 2034

            List of Tables

            1. Table 1: Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Cancer Type 2020 & 2034
            2. Table 2: Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Application 2020 & 2034
            3. Table 3: Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Product Type 2020 & 2034
            4. Table 4: Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by End User 2020 & 2034
            5. Table 5: Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Region 2020 & 2034
            6. Table 6: North America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Cancer Type 2020 & 2034
            7. Table 7: North America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Application 2020 & 2034
            8. Table 8: North America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Product Type 2020 & 2034
            9. Table 9: North America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by End User 2020 & 2034
            10. Table 10: North America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Country 2020 & 2034
            11. Table 11: USA Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
            12. Table 12: Canada Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
            13. Table 13: Mexico Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
            14. Table 14: Europe Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Cancer Type 2020 & 2034
            15. Europe Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Application 2020 & 2034

            Frequently Asked Questions

            1. How big is the AI in oncology market?

            The global AI in oncology market was valued at USD 3.1 Billion in 2025 and is projected to reach USD 32 Billion by 2035, representing a 27.2% CAGR. Estimates vary by scope definition, particularly whether enabling hardware is included.

            2. Which region leads the AI oncology market?

            North America leads with roughly 44% of 2025 global revenue, supported by FDA authorization volume and precision-oncology reimbursement. Asia-Pacific is the fastest-growing region, driven by screening capacity gaps and public digitization funding.

            3. Who are the leading AI oncology vendors?

            Tempus leads with over 9% share in 2025. The top five — Tempus, Flatiron Health, NVIDIA, Guardant Health and Paige AI — collectively hold about 45% of global revenue, indicating concentration at the top with fragmentation below.

            4. What is driving AI adoption in oncology?

            Early cancer detection demand is the strongest driver, with AI-supported mammography cutting screen-reading workload by 44% in a randomized study. Cancer prevalence, precision-oncology data synthesis and digital infrastructure are supporting drivers.

            Figure 15:
          • Figure 16: Europe Artificial Intelligence Oncology Market Report Revenue (Billion), by Product Type 2026 & 2034
          • Figure 17: Europe Artificial Intelligence Oncology Market Report Revenue Share (%), by Product Type 2026 & 2034
          • Figure 18: Europe Artificial Intelligence Oncology Market Report Revenue (Billion), by End User 2026 & 2034
          • Figure 19: Europe Artificial Intelligence Oncology Market Report Revenue Share (%), by End User 2026 & 2034
          • Figure 20: Europe Artificial Intelligence Oncology Market Report Revenue (Billion), by Country 2026 & 2034
          • Figure 21: Europe Artificial Intelligence Oncology Market Report Revenue Share (%), by Country 2026 & 2034
          • Figure 22: Asia Pacific Artificial Intelligence Oncology Market Report Revenue (Billion), by Cancer Type 2026 & 2034
          • Figure 23: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Share (%), by Cancer Type 2026 & 2034
          • Figure 24: Asia Pacific Artificial Intelligence Oncology Market Report Revenue (Billion), by Application 2026 & 2034
          • Figure 25: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Share (%), by Application 2026 & 2034
          • Figure 26: Asia Pacific Artificial Intelligence Oncology Market Report Revenue (Billion), by Product Type 2026 & 2034
          • Figure 27: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Share (%), by Product Type 2026 & 2034
          • Figure 28: Asia Pacific Artificial Intelligence Oncology Market Report Revenue (Billion), by End User 2026 & 2034
          • Figure 29: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Share (%), by End User 2026 & 2034
          • Figure 30: Asia Pacific Artificial Intelligence Oncology Market Report Revenue (Billion), by Country 2026 & 2034
          • Figure 31: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Share (%), by Country 2026 & 2034
          • Figure 32: Latin America Artificial Intelligence Oncology Market Report Revenue (Billion), by Cancer Type 2026 & 2034
          • Figure 33: Latin America Artificial Intelligence Oncology Market Report Revenue Share (%), by Cancer Type 2026 & 2034
          • Figure 34: Latin America Artificial Intelligence Oncology Market Report Revenue (Billion), by Application 2026 & 2034
          • Figure 35: Latin America Artificial Intelligence Oncology Market Report Revenue Share (%), by Application 2026 & 2034
          • Figure 36: Latin America Artificial Intelligence Oncology Market Report Revenue (Billion), by Product Type 2026 & 2034
          • Figure 37: Latin America Artificial Intelligence Oncology Market Report Revenue Share (%), by Product Type 2026 & 2034
          • Figure 38: Latin America Artificial Intelligence Oncology Market Report Revenue (Billion), by End User 2026 & 2034
          • Figure 39: Latin America Artificial Intelligence Oncology Market Report Revenue Share (%), by End User 2026 & 2034
          • Figure 40: Latin America Artificial Intelligence Oncology Market Report Revenue (Billion), by Country 2026 & 2034
          • Figure 41: Latin America Artificial Intelligence Oncology Market Report Revenue Share (%), by Country 2026 & 2034
          • Figure 42: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue (Billion), by Cancer Type 2026 & 2034
          • Figure 43: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Share (%), by Cancer Type 2026 & 2034
          • Figure 44: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue (Billion), by Application 2026 & 2034
          • Figure 45: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Share (%), by Application 2026 & 2034
          • Figure 46: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue (Billion), by Product Type 2026 & 2034
          • Figure 47: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Share (%), by Product Type 2026 & 2034
          • Figure 48: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue (Billion), by End User 2026 & 2034
          • Figure 49: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Share (%), by End User 2026 & 2034
          • Figure 50: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue (Billion), by Country 2026 & 2034
          • Figure 51: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Share (%), by Country 2026 & 2034
          • Table 15:
          • Table 16: Europe Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Product Type 2020 & 2034
          • Table 17: Europe Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by End User 2020 & 2034
          • Table 18: Europe Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Country 2020 & 2034
          • Table 19: Germany Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 20: UK Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 21: France Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 22: Italy Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 23: Spain Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 24: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Cancer Type 2020 & 2034
          • Table 25: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Application 2020 & 2034
          • Table 26: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Product Type 2020 & 2034
          • Table 27: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by End User 2020 & 2034
          • Table 28: Asia Pacific Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Country 2020 & 2034
          • Table 29: China Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 30: Japan Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 31: India Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 32: South Korea Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 33: Australia Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 34: Latin America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Cancer Type 2020 & 2034
          • Table 35: Latin America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Application 2020 & 2034
          • Table 36: Latin America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Product Type 2020 & 2034
          • Table 37: Latin America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by End User 2020 & 2034
          • Table 38: Latin America Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Country 2020 & 2034
          • Table 39: Brazil Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 40: Argentina Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 41: Mexico Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 42: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Cancer Type 2020 & 2034
          • Table 43: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Application 2020 & 2034
          • Table 44: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Product Type 2020 & 2034
          • Table 45: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by End User 2020 & 2034
          • Table 46: Middle East & Africa Artificial Intelligence Oncology Market Report Revenue Billion Forecast, by Country 2020 & 2034
          • Table 47: Saudi Arabia Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 48: UAE Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034
          • Table 49: South Africa Artificial Intelligence Oncology Market Report Revenue (Billion) Forecast, by Application 2020 & 2034